MIR6723 | microRNA 6723 | 1
| 1.117 |
LOC101928626 | NA | NA
| 1.082 |
RNA28S5 | RNA, 28S ribosomal 5 | 22p12
| 0.741 |
RNA5-8S5 | RNA, 5.8S ribosomal 5 | 22p12
| 0.703 |
RNA18S5 | RNA, 18S ribosomal 5 | 22p12
| 0.625 |
CLVS2 | clavesin 2 | 6q22.31
| 0.606 |
MRPL44 | mitochondrial ribosomal protein L44 | 2p24.3-p24.1
| 0.606 |
CALM2 | calmodulin 2 (phosphorylase kinase, delta) | 2p21.3-p21.1
| 0.606 |
DRG2 | developmentally regulated GTP binding protein 2 | 17p13-p12
| 0.606 |
C17orf75 | chromosome 17 open reading frame 75 | 17q11.2
| 0.606 |
PEX3 | peroxisomal biogenesis factor 3 | 6q24.2
| 0.606 |
MIR3687-1 | microRNA 3687-1 | 21
| 0.606 |
MIR3687-2 | microRNA 3687-2 | 21
| 0.606 |
JPX | JPX transcript, XIST activator (non-protein coding) | Xq13.2
| 0.606 |
ADAT2 | adenosine deaminase, tRNA-specific 2 | 6q24.2
| 0.605 |
MTF2 | metal response element binding transcription factor 2 | 1p22.1
| 0.605 |
NDUFS7 | NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) | 19p13
| 0.605 |
RTTN | rotatin | 18q22.1
| 0.604 |
FRA10AC1 | fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 | 10q23.33
| 0.604 |
E2F6 | E2F transcription factor 6 | 2p25.1
| 0.604 |
LOC339529 | NA | NA
| 0.603 |
IRX4 | iroquois homeobox 4 | 5p15.33
| 0.601 |
RNU2-1 | RNA, U2 small nuclear 1 | 17q12
| 0.6 |
MIR3648-1 | microRNA 3648-1 | 21
| 0.597 |
MIR3648-2 | microRNA 3648-2 | 21
| 0.597 |
PHACTR1 | phosphatase and actin regulator 1 | 6p23
| 0.577 |
DMRT1 | doublesex and mab-3 related transcription factor 1 | 9p24.3
| 0.564 |
METTL15 | methyltransferase like 15 | 11p14.1
| 0.559 |
KIF18A | kinesin family member 18A | 11p14.1
| 0.558 |
RUNX1 | runt-related transcription factor 1 | 21q22.3
| 0.534 |
MIR6724-1 | microRNA 6724-1 | 21
| 0.526 |
MIR6724-2 | microRNA 6724-2 | 21
| 0.526 |
MIR6724-3 | microRNA 6724-3 | 21
| 0.526 |
MIR6724-4 | microRNA 6724-4 | 21
| 0.526 |
MIR5707 | microRNA 5707 | 7
| 0.524 |
CTD-2194D22.4 | NA | NA
| 0.51 |
ABCC9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | 12p12.1
| 0.507 |
CCND2 | cyclin D2 | 12p13
| 0.483 |
MIR663A | microRNA 663a | 20p11.1
| 0.465 |
PTPRN2 | protein tyrosine phosphatase, receptor type, N polypeptide 2 | 7q36
| 0.449 |
MIR632 | microRNA 632 | 17q11.2
| 0.443 |
ZNF207 | zinc finger protein 207 | 17q11.2
| 0.442 |
CCND2-AS1 | CCND2 antisense RNA 1 | 12p13.32
| 0.438 |
ARHGEF18 | Rho/Rac guanine nucleotide exchange factor (GEF) 18 | 19p13.3
| 0.388 |
LOC100507412 | NA | NA
| 0.387 |
WDFY1 | WD repeat and FYVE domain containing 1 | 2q36.2
| 0.375 |
GAMT | guanidinoacetate N-methyltransferase | 19p13.3
| 0.298 |
MYO15A | myosin XVA | 17p11.2
| 0.264 |
C2orf61 | chromosome 2 open reading frame 61 | 2p21
| 0.259 |
LOC100128573 | NA | NA
| 0.246 |
LINC00854 | long intergenic non-protein coding RNA 854 | 17q21.31
| 0.244 |
DAZAP1 | DAZ associated protein 1 | 19p13.3
| 0.235 |
NRARP | NOTCH-regulated ankyrin repeat protein | 9q34.3
| 0.215 |
LOC101929034 | NA | NA
| 0.211 |
MUM1 | melanoma associated antigen (mutated) 1 | 19p13.3
| 0.202 |
OR4F29 | olfactory receptor, family 4, subfamily F, member 29 | 1p36.33
| 0.137 |
OR4F3 | olfactory receptor, family 4, subfamily F, member 3 | 5q35.3
| 0.137 |
OR4F16 | olfactory receptor, family 4, subfamily F, member 16 | 1p36.33
| 0.137 |
PEX11G | peroxisomal biogenesis factor 11 gamma | 19p13.2
| 0.132 |
TMEM106A | transmembrane protein 106A | 17q21.31
| 0.123 |
C19orf45 | chromosome 19 open reading frame 45 | 19p13.2
| 0.094 |
GID4 | GID complex subunit 4 homolog | 17p11.2
| 0.087 |
ATPAF2 | ATP synthase mitochondrial F1 complex assembly factor 2 | 17p11.2
| 0.086 |
TOR4A | torsin family 4, member A | 9q34.3
| 0.081 |
POTEA | POTE ankyrin domain family, member A | 8p11.1
| 0.074 |
C12orf5 | NA | NA
| 0.072 |
MIR610 | microRNA 610 | 11p14.1
| 0.071 |
RPS15 | ribosomal protein S15 | 19p13.3
| 0.068 |
LGI1 | leucine-rich, glioma inactivated 1 | 10q24
| 0.067 |
FUCA2 | fucosidase, alpha-L- 2, plasma | 6q24
| 0.053 |
MIR595 | microRNA 595 | 7q36.3
| 0.05 |
FRG2B | FSHD region gene 2 family, member B | 10q26.3
| 0.05 |
ZNF358 | zinc finger protein 358 | 19p13.2
| 0.045 |
APC2 | adenomatosis polyposis coli 2 | 19p13.3
| 0.043 |
GREB1 | growth regulation by estrogen in breast cancer 1 | 2p25.1
| 0.04 |
MCOLN1 | mucolipin 1 | 19p13.2
| 0.034 |
TBX5 | T-box 5 | 12q24.1
| 0.034 |
LINC00570 | long intergenic non-protein coding RNA 570 | 2p25.1
| 0.034 |
TBX5-AS1 | TBX5 antisense RNA 1 | 12q24.21
| 0.033 |
NELFB | negative elongation factor complex member B | 9q34
| 0.033 |
AKT3 | v-akt murine thymoma viral oncogene homolog 3 | 1q44
| 0.031 |
SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 2q36.1
| 0.031 |
MIR4429 | microRNA 4429 | 2
| 0.031 |
C9orf173-AS1 | C9orf173 antisense RNA 1 | 9q34.3
| 0.031 |
RHBDL3 | rhomboid, veinlet-like 3 (Drosophila) | 17q11.2
| 0.029 |
C9orf173 | chromosome 9 open reading frame 173 | 9q34.3
| 0.028 |
FAM166A | family with sequence similarity 166, member A | 9q34.3
| 0.024 |
NBR1 | neighbor of BRCA1 gene 1 | 17q21.31
| 0.024 |
LOC101929767 | NA | NA
| 0.023 |
NDUFS6 | NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) | 5p15.33
| 0.023 |
SOCS6 | suppressor of cytokine signaling 6 | 18q22
| 0.022 |
MRPL36 | mitochondrial ribosomal protein L36 | 5p15.3
| 0.022 |
PNPLA6 | patatin-like phospholipase domain containing 6 | 19p13.2
| 0.022 |
TUBB4B | tubulin, beta 4B class IVb | 9q34.3
| 0.019 |
PDE6C | phosphodiesterase 6C, cGMP-specific, cone, alpha prime | 10q24
| 0.017 |
XIST | X inactive specific transcript (non-protein coding) | Xq13.2
| 0.016 |
EXD3 | exonuclease 3'-5' domain containing 3 | 9q34.3
| 0.013 |
NOXA1 | NADPH oxidase activator 1 | 9q34.3
| 0.013 |
C19orf25 | chromosome 19 open reading frame 25 | 19p13.3
| 0.013 |
ALKBH5 | alkB homolog 5, RNA demethylase | 17p11.2
| 0.013 |
LOC100133331 | NA | NA
| 0.013 |
SLC34A3 | solute carrier family 34 (type II sodium/phosphate cotransporter), member 3 | 9q34.3
| 0.012 |
EFNA2 | ephrin-A2 | 19p13
| 0.012 |
HGSNAT | heparan-alpha-glucosaminide N-acetyltransferase | 8p11.1
| 0.011 |
ACADM | acyl-CoA dehydrogenase, C-4 to C-12 straight chain | 1p31
| 0 |
AGL | amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | 1p21
| 0 |
AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 1q42.2
| 0 |
AMPD1 | adenosine monophosphate deaminase 1 | 1p13
| 0 |
C8B | complement component 8, beta polypeptide | 1p32.2
| 0 |
CACNA1S | calcium channel, voltage-dependent, L type, alpha 1S subunit | 1q32
| 0 |
LYST | lysosomal trafficking regulator | 1q42.1-q42.2
| 0 |
CLCNKB | chloride channel, voltage-sensitive Kb | 1p36
| 0 |
CPT2 | carnitine palmitoyltransferase 2 | 1p32.3
| 0 |
DPYD | dihydropyrimidine dehydrogenase | 1p22
| 0 |
EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) | 1q42.1
| 0 |
F5 | coagulation factor V (proaccelerin, labile factor) | 1q23
| 0 |
FH | fumarate hydratase | 1q42.1
| 0 |
FUCA1 | fucosidase, alpha-L- 1, tissue | 1p34
| 0 |
GBA | glucosidase, beta, acid | 1q22
| 0 |
CFH | complement factor H | 1q32
| 0 |
HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase | 1p36.1-p35
| 0 |
HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 1p12
| 0 |
LAMB3 | laminin, beta 3 | 1q32
| 0 |
MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | 1q43
| 0 |
MYOC | myocilin, trabecular meshwork inducible glucocorticoid response | 1q23-q24
| 0 |
PKLR | pyruvate kinase, liver and RBC | 1q22
| 0 |
PKP1 | plakophilin 1 | 1q32
| 0 |
PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 1p35
| 0 |
PLOD1 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 | 1p36.22
| 0 |
PPOX | protoporphyrinogen oxidase | 1q22
| 0 |
PPT1 | palmitoyl-protein thioesterase 1 | 1p32
| 0 |
RPE65 | retinal pigment epithelium-specific protein 65kDa | 1p31
| 0 |
ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | 1p22
| 0 |
TNNT2 | troponin T type 2 (cardiac) | 1q32
| 0 |
UROD | uroporphyrinogen decarboxylase | 1p34
| 0 |
CTSK | cathepsin K | 1q21
| 0 |
GALE | UDP-galactose-4-epimerase | 1p36-p35
| 0 |
LOR | loricrin | 1q21
| 0 |
NCF2 | neutrophil cytosolic factor 2 | 1q25
| 0 |
PAFAH2 | platelet-activating factor acetylhydrolase 2, 40kDa | 1p34.3
| 0 |
PSEN2 | presenilin 2 | 1q42.13
| 0 |
RFX5 | regulatory factor X, 5 (influences HLA class II expression) | 1q21
| 0 |
SELE | selectin E | 1q24.2
| 0 |
ALPL | alkaline phosphatase, liver/bone/kidney | 1p36.12
| 0 |
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 1q25.1
| 0 |
C1QB | complement component 1, q subcomponent, B chain | 1p36.3-p34.1
| 0 |
MPZ | myelin protein zero | 1q22
| 0 |
REN | renin | 1q32
| 0 |
TSHB | thyroid stimulating hormone, beta | 1p13
| 0 |
CD53 | CD53 molecule | 1p13
| 0 |
GSTM1 | glutathione S-transferase mu 1 | 1p13.3
| 0 |
C8A | complement component 8, alpha polypeptide | 1p32.2
| 0 |
IL6R | interleukin 6 receptor | 1q21
| 0 |
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) | 1q21.2-q21.3
| 0 |
CRP | C-reactive protein, pentraxin-related | 1q23.2
| 0 |
FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | 1q23
| 0 |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 1q23
| 0 |
IL10 | interleukin 10 | 1q31-q32
| 0 |
CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 1q32
| 0 |
CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 1q32
| 0 |
FASLG | Fas ligand (TNF superfamily, member 6) | 1q23
| 0 |
SELL | selectin L | 1q24.2
| 0 |
ADORA1 | adenosine A1 receptor | 1q32.1
| 0 |
ADORA3 | adenosine A3 receptor | 1p13.2
| 0 |
ALDH9A1 | aldehyde dehydrogenase 9 family, member A1 | 1q24.1
| 0 |
AMY2A | amylase, alpha 2A (pancreatic) | 1p21.1
| 0 |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | 1p13
| 0 |
ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 1q23.2
| 0 |
AVPR1B | arginine vasopressin receptor 1B | 1q32
| 0 |
C4BPA | complement component 4 binding protein, alpha | 1q32
| 0 |
C4BPB | complement component 4 binding protein, beta | 1q32
| 0 |
CACNA1E | calcium channel, voltage-dependent, R type, alpha 1E subunit | 1q25.3
| 0 |
CD247 | CD247 molecule | 1q24.2
| 0 |
CHRM3 | cholinergic receptor, muscarinic 3 | 1q43
| 0 |
CHRNB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) | 1q21.3
| 0 |
CSF1 | colony stimulating factor 1 (macrophage) | 1p13.3
| 0 |
CSF3R | colony stimulating factor 3 receptor (granulocyte) | 1p35-p34.3
| 0 |
CYP2J2 | cytochrome P450, family 2, subfamily J, polypeptide 2 | 1p31.3-p31.2
| 0 |
CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 1p33
| 0 |
CYP4B1 | cytochrome P450, family 4, subfamily B, polypeptide 1 | 1p33
| 0 |
DIO1 | deiodinase, iodothyronine, type I | 1p33-p32
| 0 |
GABRD | gamma-aminobutyric acid (GABA) A receptor, delta | 1p36.3
| 0 |
GRIK3 | glutamate receptor, ionotropic, kainate 3 | 1p34.3
| 0 |
GSTM2 | glutathione S-transferase mu 2 (muscle) | 1p13.3
| 0 |
GSTM3 | glutathione S-transferase mu 3 (brain) | 1p13.3
| 0 |
GSTM4 | glutathione S-transferase mu 4 | 1p13.3
| 0 |
GSTM5 | glutathione S-transferase mu 5 | 1p13.3
| 0 |
GUK1 | guanylate kinase 1 | 1q32-q41
| 0 |
HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | 1p12
| 0 |
HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | 1p36.3-p34.3
| 0 |
HTR6 | 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled | 1p36-p35
| 0 |
NPR1 | natriuretic peptide receptor 1 | 1q21-q22
| 0 |
OPRD1 | opioid receptor, delta 1 | 1p36.1-p34.3
| 0 |
PLA2G5 | phospholipase A2, group V | 1p36-p34
| 0 |
PTAFR | platelet-activating factor receptor | 1p35-p34.3
| 0 |
PTGFR | prostaglandin F receptor (FP) | 1p31.1
| 0 |
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 1q25.2-q25.3
| 0 |
RPL5 | ribosomal protein L5 | 1p22.1
| 0 |
RPL11 | ribosomal protein L11 | 1p36.1-p35
| 0 |
RPL22 | ribosomal protein L22 | 1p36.31
| 0 |